Invesaro

Stocks Comparison

Avanos Medical vs STERIS: revenue, profit, margins and growth compared

Avanos Medical brought in $701.2M of revenue in fiscal 2025, STERIS $5.9B in fiscal 2026. Revenue changed by +1.9% at Avanos Medical and +8.7% at STERIS on the year before, so STERIS grew faster. Avanos Medical kept -10.4% of its revenue as net profit, STERIS 13.2%. Free cash flow was $43.1M at Avanos Medical and $972.4M at STERIS.

Side by side, latest fiscal year

AVNSSTE
Fiscal year endedFY2025 (December 31, 2025)FY2026 (March 31, 2026)
Revenue$701.2M$5.9B
Revenue growth+1.9%+8.7%
Net income-$72.9M$782.3M
Net margin-10.4%13.2%
Free cash flow$43.1M$972.4M
Free cash flow margin6.1%16.4%
Earnings per share (diluted)-$1.57$7.93
Cash$89.8M$439.6M
Debt$90.3M$1.8B
Price to earningsn/a26.4
Market valuen/a$20.4B
Dividend yieldn/a1.18%
Rank by revenue in sector#175 of 646 · Health care#56 of 646 · Health care

Over the years

Revenue
AVNS FY2018: $652.3MAVNS FY2019: $697.6MAVNS FY2020: $714.8MAVNS FY2021: $587MAVNS FY2022: $684.1MAVNS FY2023: $673.3MAVNS FY2024: $687.8MAVNS FY2025: $701.2MSTE FY2019: $2.8BSTE FY2020: $3BSTE FY2021: $3.1BSTE FY2022: $4.2BSTE FY2023: $4.5BSTE FY2024: $5.1BSTE FY2025: $5.5BSTE FY2026: $5.9BFY18FY19FY20FY21FY22FY23FY24FY25FY26
AVNS $701.2MSTE $5.9B
Net income
AVNS FY2018: $57.5MAVNS FY2019: -$45.9MAVNS FY2020: -$29MAVNS FY2021: $6.3MAVNS FY2022: $50.5MAVNS FY2023: -$61.8MAVNS FY2024: -$392.1MAVNS FY2025: -$72.9MSTE FY2019: $303.7MSTE FY2020: $407.7MSTE FY2021: $397.4MSTE FY2022: $243.9MSTE FY2023: $107MSTE FY2024: $378.2MSTE FY2025: $614.6MSTE FY2026: $782.3MFY18FY19FY20FY21FY22FY23FY24FY25FY26
AVNS -$72.9MSTE $782.3M
Net margin
AVNS FY2018: 8.8%AVNS FY2019: -6.6%AVNS FY2020: -4.1%AVNS FY2021: 1.1%AVNS FY2022: 7.4%AVNS FY2023: -9.2%AVNS FY2024: -57.0%AVNS FY2025: -10.4%STE FY2019: 10.9%STE FY2020: 13.5%STE FY2021: 12.8%STE FY2022: 5.8%STE FY2023: 2.4%STE FY2024: 7.4%STE FY2025: 11.3%STE FY2026: 13.2%FY18FY19FY20FY21FY22FY23FY24FY25FY26
AVNS -10.4%STE 13.2%
Revenue growth
AVNS FY2019: +6.9%AVNS FY2020: +2.5%AVNS FY2021: -17.9%AVNS FY2022: +16.5%AVNS FY2023: -1.6%AVNS FY2024: +2.2%AVNS FY2025: +1.9%STE FY2020: +8.9%STE FY2021: +2.5%STE FY2022: +35.9%STE FY2023: +7.4%STE FY2024: +13.3%STE FY2025: +6.2%STE FY2026: +8.7%FY19FY20FY21FY22FY23FY24FY25FY26
AVNS +1.9%STE +8.7%
Free cash flow
AVNS FY2018: -$194.7MAVNS FY2019: -$125.1MAVNS FY2020: -$22.7MAVNS FY2021: $66.3MAVNS FY2022: $71.6MAVNS FY2023: $14.6MAVNS FY2024: $82.9MAVNS FY2025: $43.1MSTE FY2019: $349.8MSTE FY2020: $376MSTE FY2021: $450.4MSTE FY2022: $397.2MSTE FY2023: $395MSTE FY2024: $613MSTE FY2025: $778MSTE FY2026: $972.4MFY18FY19FY20FY21FY22FY23FY24FY25FY26
AVNS $43.1MSTE $972.4M

Fiscal years as each company reports them; the two may end in different months.

Questions about Avanos Medical and STERIS

Which is bigger by revenue, Avanos Medical or STERIS?

STERIS is bigger by revenue: $5.9B in fiscal 2026, against $701.2M for Avanos Medical in fiscal 2025.

Which keeps more of its revenue as profit, Avanos Medical or STERIS?

Avanos Medical had a net margin of -10.4% in fiscal 2025; STERIS had 13.2% in fiscal 2026.

Which grew revenue faster, Avanos Medical or STERIS?

In their latest fiscal years revenue changed by +1.9% at Avanos Medical and +8.7% at STERIS.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies